Home/Pipeline/Pipeline Oncology

Pipeline Oncology

Cancer

UnknownActive

Key Facts

Indication

Cancer

Phase

Unknown

Status

Active

Company

BioQ Pharma

About BioQ Pharma

BioQ Pharma is a commercial-stage biotech company developing and commercializing proprietary, pre-filled, ready-to-use infusion systems for hard-to-prepare drugs. Its core invenious™ platform is designed to enhance safety, sterility, and convenience while reducing medication errors and total cost of care. The company has launched its first product, Ropivacaine Readyfusor, for post-surgical pain and is building a pipeline across anesthesia, sedation, antibiotics, and oncology.

View full company profile

Therapeutic Areas

Post-Surgical Pain Anesthesia Sedation Anti-infectives Oncology

Other Cancer Drugs

Drug	Company	Phase	Status
Not Specified (Oncology Focus)	Narwhal Bio	Pre-clinical	Active
EDM Platform for Genetic Medicine	Coastar Therapeutics	Pre-clinical	Platform Development
CO-1	Caedo Oncology	Pre-clinical	Active R&D
Anti-CD99 monoclonal antibody	Caedo Oncology	Discovery/Pre-clinical	Proprietary antibody identified
Anti-HLA class I monoclonal antibody	Caedo Oncology	Discovery/Pre-clinical	Proprietary antibody identified
Triapine®	Nanopharmaceutics	Clinical	Active
Ammonium Tetrathiomolybdate	Nanopharmaceutics	Clinical	Active
Aza-TdC	Nanopharmaceutics	Clinical	Active
Undisclosed Oncology Program(s)	Cell BioEngines	Phase 1	Active
No-alpha IL-2 Mutein	SarcoMed USA	Pre-clinical	Active
PMIS Therapeutic	NaturemiRI	Preclinical/Clinical (unspecified)	Active
AUM302 (formerly IBL-302)	Inflection Biosciences	Pre-clinical (partnered)	Active